ARTICLE | Distillery Therapeutics
eIF4E identified as target in obesity, fatty liver disease
April 7, 2021 12:12 AM UTC
DISEASE CATEGORY: Endocrine/metabolic
INDICATION: Obesity; liver disease...
BCIQ Company Profiles
BCIQ Target Profiles
DISEASE CATEGORY: Endocrine/metabolic
INDICATION: Obesity; liver disease...
BCIQ Company Profiles
BCIQ Target Profiles
BCIQ Company Profiles
BCIQ Target Profiles